5 Healthcare Stocks Under $10 Ready To Pop
Investing in the healthcare sector can be tricky, especially if you're looking for high returns and want to invest in clinical-stage companies, which represent an above-average risk.
Orexigen Therapeutics Inc (OREX)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
You Should Follow Hedge Funds Into One Semiconductor and One Healthcare Stock
In the first hours of trading, the markets showed slight signs of improvement, impacted by positive jobless claims data.
Foresite Capital Betting It All On These Four Healthcare Stocks
Jim Tananbaum’s Foresite Capital has filed its latest 13F with the Securities and Exchange Commission for the reporting period of March 31, disclosing the long positions held in its equity portfolio...
Five Hedge Fund Moves in Healthcare Sector From This Week
The healthcare sector is usually very attractive to investors, since the companies involved in it have a great potential to grow.
Partner Fund Management Ups Stake in Orexigen Therapeutics, Inc. (OREX)
Christopher Medlock James', San Francisco-based, hedge fund Partner Fund Management has raised its position in Orexigen Therapeutics, Inc. (NASDAQ:OREX), a new filing with the SEC showed.
Arena Pharmaceuticals, Inc. (ARNA): Are Investors Worried?
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued a press release pointing out that its marketing partner Eisai had started direct-to-consumer advertising for their obesity drug Belviq, including a full...
Here is What Hedge Funds Think About Dynavax Technologies Corporation (DVAX)
If you were to ask many market players, hedge funds are seen as useless, outdated financial vehicles of a forgotten age.
Arena Pharmaceuticals, Inc. (ARNA), Orexigen Therapeutics, Inc. (OREX): VIVUS, Inc. (VVUS) Gets 3 CEOs in Less Than Two Months
The first guy, Leland Wilson, got kicked out. Never mind that he founded the company, Samuel Colin, senior managing partner at First Manhattan, VIVUS, Inc.
Should You Avoid Orexigen Therapeutics, Inc. (OREX)?
In the financial world, there are a multitude of metrics shareholders can use to watch their holdings. A couple of the most innovative are hedge fund and insider trading movement.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Third Obesity Drug Moves Closer to FDA Approval
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s Belviq, VIVUS, Inc. (NASDAQ:VVUS)'s Qsymia, and Orexigen Therapeutics, Inc. (NASDAQ:OREX)'s Contrave were rejected by the Food and Drug Administration within...
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
